Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Preliminary Results: Correction

21 Mar 2019 09:00

RNS Number : 5148T
Impellam Group plc
21 March 2019
 

 

 

 

 

PRELIMINARY RESULTS - UNAUDITED

 CORRECTION

 

Impellam Group plc ("Impellam" or ''the Group'') - London AIM: IPEL: 21 March 2019

 

Further to its preliminary unaudited results announcement released on 14 March 2019, the Company wishes to make the following amendments in respect of adjusted EPS, which was under-stated in that announcement due to the treatment of deferred tax on the adjustments to profit - primarily the impairment of goodwill. The correction results in the following increases to adjusted EPS and adjusted profit as follows:

 

 

 

FY 2018

FY 2017

Actual Inc/(Dec)

 

Previously Reported

 

 

 

 

 

 

 

 

 

Adjusted Basic EPS (1)

 

56.8p

74.6p

(23.9)%

 

 

 

 

 

Corrected

 

Adjusted Basic EPS (1)

 

60.8p

75.2p

(19.1)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Before separately disclosed items, impairment, customer relationship amortisation and share-based payments. Explanation of this Alternative Performance Measure is below

 

 

Alternative Performance Measures

 

Adjusted earnings per share (EPS)

Definition: Adjusted profit divided by the weighted average number of ordinary shares outstanding during the year.

Closest equivalent IFRS measure: Basic earnings per share

Rationale for adjustment: The Group uses this measure alongside the basic EPS calculation as it reflects the underlying trading performance of the business.

 

 

 

The corrected tables below reflect an increase in impairment of goodwill (the adjustment was previously shown net of tax but is now shown as the gross value), as well as higher customer relationship amortisation, resulting in higher adjusted profit and EPS.

Reconciliation of Adjusted EPS to Basic EPS:

 

2018

2017

 

£m

£m

Profit for the period

13.3

31.1

Separately disclosed items (net of tax)

4.9

3.3

Impairment of goodwill

8.6

-

Customer relationship amortisation (net of tax)

3.7

3.4

Adjusted profit

30.5

37.8

 

 

 

Weighted average number of shares

50,171,830

50,322,196

 

 

 

Basic EPS

26.5

61.9

Adjusted EPS

60.8

75.2

 

The Company expects to issue its audited annual report later today, which will be made available on the Company's website at www.impellam.com

 

[END]

 

For further information please contact:

 

Impellam Group plc

Julia Robertson, Group Chief Executive Tel: + 44 (0)1582 692658

 

Cenkos Securities plc (NOMAD and Corporate Broker to Impellam)

Nicholas Wells Tel: +44 (0)20 7397 8900

Callum Davidson

 

Note to Editors:

 

Impellam is the second largest1 staffing business in the UK and sixth largest2 managed services provider worldwide. Our vision is to be the world's most trusted staffing company - trusted by our people, our customers and our investors in equal measure.

 

We provide Managed Services and Specialist Staffing solutions across the UK, Europe, US, the Middle East and Australasia. We have over 3,200 Impellam people throughout our network of 17 market-leading brands across 165 worldwide locations.

 

Ultimately, Impellam Group's mission is to provide fulfilment and a sense of purpose to our people and to help customers build better businesses in a changing world.

 

For more information about Impellam Group please visit: www.impellam.com

 

1 By revenue (2017 published numbers)

2 By SUM (confirmed by Staffing Industry Analysts). Spend Under Management (SUM) is the total amount of client expenditure which our Managed Services brands manage on behalf of their clients. This equates to revenue earned where Impellam acts as principal plus gross billings to customers where Impellam acts as agent (2017 published numbers). Management use this measure as it reflects the total value of the client spend to the Group and not just the revenue generated

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FURJMMTTMBATTAL
Date   Source Headline
13th Oct 202312:30 pmRNSForm 8.3 - Impellam Group PLC
13th Oct 202310:56 amRNSForm 8.5 (EPT/RI)
13th Oct 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
12th Oct 202310:08 amRNSForm 8.3 - Impellam Group PLC
11th Oct 20233:20 pmRNSExtension of PUSU deadline
11th Oct 202311:20 amRNSForm 8.3 - Impellam Group PLC
10th Oct 202310:57 amRNSForm 8.5 (EPT/RI)
10th Oct 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
9th Oct 20231:37 pmRNSForm 8.3 - Impellam Group PLC
9th Oct 202310:36 amRNSForm 8.5 (EPT/RI)
9th Oct 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
6th Oct 202311:24 amRNSForm 8.3 - Impellam Group Plc
6th Oct 202311:05 amRNSForm 8.5 (EPT/RI)
6th Oct 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
4th Oct 202311:17 amRNSForm 8.3 - Impellam Group Plc
4th Oct 202311:13 amRNSForm 8.3 - Impellam Group Plc
3rd Oct 202311:48 amRNSForm 8.5 (EPT/RI)
3rd Oct 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
27th Sep 20234:35 pmRNSExtension of PUSU Deadline
27th Sep 202311:40 amRNSForm 8.3 - Impellam Group plc
22nd Sep 202310:33 amRNSForm 8.3 - Impellam Group PLC
21st Sep 202311:38 amRNSForm 8.3 - Impellam Group PLC
20th Sep 20233:08 pmRNSExtension of PUSU Deadline
20th Sep 202311:50 amRNSForm 8.5 (EPT/RI) - Impellam Group plc
20th Sep 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
18th Sep 20232:17 pmRNSForm 8.3 - IMpellam Group PLC
15th Sep 202310:03 amRNSForm 8.3 - Impellam Group Plc
14th Sep 202310:45 amRNSForm 8.3 - Impellam Group PLC
12th Sep 202311:25 amRNSForm 8.3 - Impellam Group PLC
8th Sep 202310:36 amBUSForm 8.3 - Impellam Group Plc
8th Sep 20239:52 amRNSForm 8.5 (EPT/RI)
8th Sep 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
7th Sep 202311:23 amRNSForm 8.5 (EPT/RI) - Impellam Group plc
7th Sep 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
31st Aug 20233:17 pmRNSExtension of PUSU Deadline
31st Aug 202310:02 amRNSForm 8.5 (EPT/RI)
31st Aug 20238:49 amBUSForm 8.3 - Impellam Group Plc
31st Aug 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
23rd Aug 202311:18 amRNSForm 8.5 (EPT/RI)
23rd Aug 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
22nd Aug 202310:46 amRNSForm 8.3 - Impellam Group PLC
22nd Aug 20239:49 amRNSForm 8.5 (EPT/RI)
21st Aug 20234:31 pmRNSINTERIM RESULTS TO 30 JUNE 2023
21st Aug 20234:31 pmRNSExtension of PUSU deadline
17th Aug 20238:30 amRNSForm 8.5 (EPT/RI)
16th Aug 202310:38 amRNSForm 8.3 - Impellam Group Plc
15th Aug 202310:38 amRNSForm 8.3 - Impellam Group PLC
14th Aug 20239:47 amRNSForm 8.3 - Impellam Group PLC
11th Aug 20233:03 pmRNSExtension of PUSU Deadline
11th Aug 202311:03 amRNSForm 8.3 - Impellam Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.